Literature DB >> 15921177

Gonadal function of young patients with beta-thalassemia following bone marrow transplantation.

Elpis Vlachopapadopoulou1, V Kitra, J Peristeri, E Goussetis, F Karachaliou, D Petropoulos, A Fotinou, S Michalacos, S Graphakos.   

Abstract

Bone marrow transplantation (BMT) can induce short- and long-term impairment of gonadal function. Patients with beta-thalassemia represent a special group, as their primary diagnosis and its treatment modalities are responsible for gonadal dysfunction. To address the effect of BMT on puberty and gonadal function, we investigated 25 patients (12 males) with thalassemia who received allogenic BMT during childhood or adolescence and at the post-transplant evaluation were at an age that the pubertal process should have started. Pubertal stage by Tanner of breast and pubic hair, as well as testicular volume were assessed pre-BMT once and post-BMT at least twice. Menstrual history was recorded. FSH, LH, testosterone and estradiol levels were also determined. The impact of BMT appears to be different in the two sexes. Males seem to have higher tolerance, as all males who were pubertal at the time of BMT had normal testosterone, and all but one normal gonadotropin levels. From those who were prepubertal at BMT, 62% proceeded to normal pubertal development. Post-menarcheal females seem to be an extremely sensitive group to the deleterious effect of the transplantation process, as 100% of the post-menarcheal females exhibited amenorrhea and elevated gonadotropin levels. These findings are important for pre- and post-BMT counseling.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15921177     DOI: 10.1515/jpem.2005.18.5.477

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  6 in total

1.  Oocyte cryopreservation in a patient with sickle cell disease prior to hematopoietic stem cell transplantation: first report.

Authors:  Serena Dovey; Lakshmanan Krishnamurti; Joseph Sanfilippo; Sriya Gunawardena; Patricia Mclendon; Mary Campbell; Sandra Alway; Brenda Efymow; Clarisa Gracia
Journal:  J Assist Reprod Genet       Date:  2012-01-05       Impact factor: 3.412

Review 2.  HSCT remains the only cure for patients with transfusion-dependent thalassemia until gene therapy strategies are proven to be safe.

Authors:  Christina Oikonomopoulou; Evgenios Goussetis
Journal:  Bone Marrow Transplant       Date:  2021-09-16       Impact factor: 5.483

Review 3.  A Short Review on Growth and Endocrine Long-term Complications in Children and Adolescents with β-Thalassemia Major: Conventional Treatment versus Hematopoietic Stem Cell Transplantation.

Authors:  Shayma Ahmed; Ashraf Soliman; Vincenzo De Sanctis; Nada Alaaraj; Fawzia Alyafei; Noor Hamed; Mohamed Yassin
Journal:  Acta Biomed       Date:  2022-08-31

Review 4.  Advancing the care of β-thalassaemia patients with novel therapies.

Authors:  Rayan Bou-Fakhredin; Irene Motta; Maria Domenica Cappellini
Journal:  Blood Transfus       Date:  2021-10-21       Impact factor: 3.443

5.  Late effects after hematopoietic stem cell transplantation for β-thalassemia major: the French national experience.

Authors:  Ilhem Rahal; Claire Galambrun; Yves Bertrand; Nathalie Garnier; Catherine Paillard; Pierre Frange; Corinne Pondarré; Jean Hugues Dalle; Regis Peffault de Latour; Mauricette Michallet; Dominique Steschenko; Despina Moshous; Patrick Lutz; Jean Louis Stephan; Pierre Simon Rohrlich; Ibrahim Yakoub-Agha; Françoise Bernaudin; Christophe Piguet; Nathalie Aladjidi; Catherine Badens; Claire Berger; Gérard Socié; Cécile Dumesnil; Marie Pierre Castex; Marilyne Poirée; Anne Lambilliotte; Caroline Thomas; Pauline Simon; Pascal Auquier; Gérard Michel; Anderson Loundou; Imane Agouti; Isabelle Thuret
Journal:  Haematologica       Date:  2018-03-29       Impact factor: 9.941

6.  Indicators of male fertility potential in adult patients with beta-thalassemia major: a comparative study between patients undergone allogeneic stem cell transplantation and transfusion-dependent patients.

Authors:  Tahereh Rostami; Mohammad Amir Mohammadifard; Shahla Ansari; Azadeh Kiumarsi; Nasrollah Maleki; Amir Kasaeian; Fatemeh Aghamahdi; Soroush Rad; Ardeshir Ghavamzadeh
Journal:  Fertil Res Pract       Date:  2020-03-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.